Incorporated in 1999, Gujarat based Par Drugs and Chemicals Limited is engaged in the business of manufacturing and developing active pharma ingredients (API) for the Indian and international markets. APIs are used as the main ingredient in making tablets, capsules, and other finished dosages. The company also produces various antacid molecules. It has two manufacturing facilities located at Ankleshwar and Bhavnagar in Gujarat.Currently, the company has a total of 6 Fine Chemical and 12 API products which are available in the market of 17 countries, including
India. Some of the customers of the company are Dabur India Ltd, Meyer Organics Pvt. Ltd, Cadila Healthcare Ltd., Cipla Ltd, and Pfizer Ltd. For fiscal 2018, the international and domestic operations recorded 86.88% and 13.12%, respectively from the total company sales. The company has a testing laboratory to maintain quality standards for finished products and raw materials. Par Drugs and Chemicals Ltd also performs drying operations of the products provided by customers in the liquid form and converts them into powders.
The competitive strengths of the company are:
1. Diversified product range
2. International presence
3. Prompt sales & distribution network
4. A good track record
5. Strong chemistry capabilities
Company Promoters:
Falgun Vallabhbhai Savani and Jignesh Vallabhbhai Savani are the promoters of the company.
Company Financials:
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
30-Sep-18 31-Mar-18 31-Mar-17 31-Mar-16
Particulars For the year/period ended (in Rs. Lakhs)
Total Assets 5,565.09 5,393.89 5,604.14 5,803.08
Total Revenue 2,486.16 4,237.64 4,876.61 3,326.43
Profit After Tax 136.77 149.53 184.78 42.18
Objects of the Issue:
The Net Proceeds from Issue towards the following objects:
1. Funding the working capital requirements of the Company; and
2. General corporate purposes.
Par Drugs IPO Details
Issue Open May 3, 2019 - May 8, 2019
Issue Type Fixed Price Issue IPO
Issue Size 1,672,000 Eq Shares of Rs 10
(aggregating up to Rs 8.53 Cr)
Fresh Issue 1,672,000 Eq Shares of Rs 10
(aggregating up to Rs [.] Cr)
Face Value Rs 10 Per Equity Share
Issue Price Rs 51 Per Equity Share
Market Lot 2000 Shares
Min Order Quantity 2000 Shares
Listing At NSE SME
Par Drugs IPO Tentative Date / Timetable
Bid/Offer Opens On May 3, 2019
Bid/Offer Closes On May 8, 2019
Finalisation of Basis of Allotment May 13, 2019
Initiation of Refunds May 14, 2019
Credit of Shares to Demat Acct: May 15, 2019
IPO Shares Listing Date: May 16, 2019
Par Drugs IPO Promoter Holding
Pre Issue Share Holding 99.55%
Post Issue Share Holding 72.82
Company Contact Information
Par Drugs and Chemicals Limited
805, Dwarkesh Complex,
R.C. Dutt Road,
Alkapuri, Vadodara-390 007,
Phone: +91 265 2332018
Email: cs.sanket@pardrugs.com
Website: http://pardrugs.com/
Par Drugs IPO Registrar
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: pardrugs.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
Latest Share Market News, Latest Share News, Latest Share Market Tips, Latest Share Market Videos, Latest Share Market News In Hindi, Latest Share Recommendations , Latest Stock Market News, Latest Stock Market Recommendations , Latest Stock Market News India, Latest Stock News India, Latest Stock Picks, Latest Stock Market Analysis Market Watch, Latest Stock Market Videos
No comments:
Post a Comment